Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
申请人:——
公开号:US20040254231A1
公开(公告)日:2004-12-16
The present invention provides compounds of Formula (I):
1
or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein the variables L, Z
0
, R
1
, R
4
, R
5
, and R
11
are defined are as defined herein, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-&agr; converting enzyme (TACE), aggrecanase, or a combination thereof.